ANTIALLERGICAL BIOPOLYMERS OF MARINE ORIGIN

摘要

The invention relates to pharmaceutical compositions based on carrageenan as an active substance, which are intended for use as a medicine in the prophylactic or therapeutic treatment of allergic conditions or diseases, provided that the carrageenan includes iota and / or kappa-carrageenan and practically does not contain lambda -carrageenan. Typically, the invention relates to liquid compositions, gels, and dry powder compositions comprising iota and / or kappa carrageenan and optionally one or more non-carrageenan therapeutic agents for administration to the respiratory tract, gastrointestinal tract, or eyes. The compositions of the invention have been found to be effective in the prophylaxis and treatment of type I allergies and can additionally exhibit adjuvant function when administered to mucous membranes combined with non-carrageenan therapeutic agents.